NEST Scientific — The Trusted Partner for 503A & 503B Compounding Pharmacies
As the regulatory landscape tightens and patient demand for advanced injectable therapies continues to grow, 503A and 503B compounding pharmacies need partners who understand compliance, quality, and scalability.
NEST delivers all three.
From pen injectors and RTU cartridges to fully validated automatic injection systems, NEST provides drug-device combination solutions designed for safety, efficiency, and regulatory confidence.
Understanding the Needs of 503A and 503B Pharmacies
-
503A Pharmacies focus on patient-specific compounding with flexibility and customization.
-
503B Outsourcing Facilities operate under CGMP requirements, producing larger batches for healthcare systems and clinics.
Both require:
-
Reliable supply chains
-
Validated, compliant medical devices
-
Accurate dose delivery systems
-
Documentation to support inspections and audits
-
Safe, patient-friendly self-administration solutions
NEST was built with these requirements in mind.
Advanced Pen Injector & Self-Administration Platforms




NEST offers a complete portfolio of injection platforms compatible with medications such as semaglutide, liraglutide, insulin, FSH, and other hormone or GLP-1 therapies commonly compounded in 503A and 503B settings.
Product Portfolio Includes:
-
Disposable Pen Injectors (Standard, SP, TSA)
-
Self-Locking Pen Injectors (100 IU)
-
Fixed-Dose Pen Injectors
-
Prefilled Automatic Pen Injectors (Two-Step & Three-Step)
-
RTU Cartridges (EO or steam sterilized)
For compounding pharmacies offering weight management, hormone therapy, fertility treatment, or metabolic therapies, these delivery systems enhance both compliance and patient experience.
Built for Compliance: Certifications & Regulatory Support
Compounding pharmacies cannot afford regulatory risk. NEST provides a strong compliance foundation:
-
FTO (Freedom to Operate) analysis covering U.S., U.K., Europe, and China
Production lines follow GMP standards with third-party monitoring throughout the process.
For 503B facilities operating under FDA CGMP standards, this level of validation and documentation support is critical during audits and inspections.
Comprehensive Product Validation
NEST conducts extensive verification testing in accordance with ISO 11608 standards (pen injector requirements).
Testing includes:
-
Final dose accuracy
-
Free-fall dose accuracy
-
Injection start force
-
Cold / warm / humid / frozen environmental testing
-
Vibration testing
-
Lifecycle testing (4,500+ cycles)
-
Needle compatibility & torque validation
-
Leakage testing
-
Stability verification (1-, 3-, and 5-year accelerated aging)
This ensures pharmacies can confidently provide drug-device combinations that meet performance expectations even under challenging storage and transport conditions.
Full In-House Manufacturing = Faster Customization


Unlike many suppliers that outsource critical components, NEST operates a fully integrated industry chain:
-
Independent mold design & manufacturing
-
Polymer material expertise (PP, PC, medical-grade plastics)
-
Automated injection molding
-
Optical inline inspection
-
Three-coordinate measurement systems (ZEISS)
-
Industrial CT scanning for precision validation
Facilities include:
-
10,600㎡ Class 100,000 cleanroom
-
3,600㎡ Class 10,000 cleanroom
-
2,300㎡ pen injector controlled workshop
For 503A pharmacies requiring smaller customized batches or 503B facilities needing scalable production, this flexibility reduces lead time and ensures consistent quality.
RTU Cartridges Designed for Sterility & Safety
NEST RTU cartridges are:
-
100% inline optically inspected
-
Available pre-sterilized (SAL 10⁻⁶)
-
Compatible with EO or steam sterilization
-
Manufactured in GMP-controlled cleanrooms
-
Packaged in Nest-pack configurations to reduce breakage
For outsourcing facilities managing sterile injectables, validated RTU components reduce processing burden and contamination risk.
Assembly Equipment for 503B Scaling
For larger outsourcing facilities, NEST also offers:
-
TSA disposable pen press-fitting equipment
-
Prefilled automatic pen injector assembly systems
-
Automated cartridge insertion lines
-
Vision inspection systems
-
Pressure and performance testing stations
This enables 503B pharmacies to move toward scalable, semi-automated drug-device combination assembly while maintaining compliance and traceability.
Global Supply Chain Stability
NEST supports U.S. customers through:
-
Long-term supply contracts
-
Safety stock programs
-
Full batch traceability
-
Retained sample programs
-
Transportation inspection controls
For compounding pharmacies managing fluctuating demand in GLP-1 or hormone markets, supply continuity is a competitive advantage.
Why 503A & 503B Pharmacies Choose NEST
1. Compliance-Driven Manufacturing
GMP production, global certifications, and documented validation support inspection readiness.
2. Dose Accuracy & Patient Safety
Extensive performance testing ensures reliable administration.
3. Customization Capability
Dose units, graduation marks, colors, packaging, and branding can be tailored.
4. Scalable Solutions
From small compounding operations to high-volume outsourcing facilities.
5. End-to-End Support
From RTU cartridges to finished pen injector systems and assembly equipment.
The Bottom Line
In today’s environment, compounding pharmacies need more than a component supplier. They need a strategic manufacturing partner that understands compliance, sterility, performance validation, and supply chain security.
NEST delivers:
-
Fully validated pen injector systems
-
Drug-device compatibility
-
Regulatory-ready documentation
-
Scalable production capabilities
-
Global distribution with U.S. infrastructure
For 503A and 503B pharmacies looking to enhance their injectable offerings while reducing regulatory risk, NEST is not just a supplier it’s a long-term partner in precision, compliance, and patient safety.







